首页> 外国专利> APPLICATION OF CATHEPSIN E AS TUMOR MARKER AND APPLICATION OF CATHEPSIN E AND CATHEPSIN D AS TARGET FOR THERAPY FOR INHIBITING TUMOR ANGIOGENESIS

APPLICATION OF CATHEPSIN E AS TUMOR MARKER AND APPLICATION OF CATHEPSIN E AND CATHEPSIN D AS TARGET FOR THERAPY FOR INHIBITING TUMOR ANGIOGENESIS

机译:组织蛋白酶E作为肿瘤标志物的应用及组织蛋白酶E和组织蛋白酶D作为靶点在抑制肿瘤血管生成中的应用

摘要

PROBLEM TO BE SOLVED: To use cathepsin D or cathepsin E as a tumor marker.;SOLUTION: Growth proliferation and metastaticity (malignancy) of a tumor cell are determined by using cathepsin E as a tumor marker for tumors such as epidermoid cancer and measuring cathepsin E in serum. The cathepsin D or cathepsin E is introduced as a protein or a gene into the tumor cell. Thereby, enhancement of angiostatin production ability of cathepsin D and endostatin production ability of cathepsin E is induced and growth proliferation and metastasis of the tumor cell can be suppressed.;COPYRIGHT: (C)2005,JPO&NCIPI
机译:解决的问题:使用组织蛋白酶D或组织蛋白酶E作为肿瘤标志物;解决方案:通过使用组织蛋白酶E作为表皮样癌等肿瘤的肿瘤标志物来确定肿瘤细胞的生长增殖和转移性(恶性)。血清中的E。组织蛋白酶D或组织蛋白酶E作为蛋白质或基因被引入肿瘤细胞。从而诱导组织蛋白酶D的血管抑制素产生能力的增强和组织蛋白酶E的内皮抑素产生能力的增强,并且可以抑制肿瘤细胞的生长增殖和转移。;版权所有:(C)2005,JPO&NCIPI

著录项

  • 公开/公告号JP2005117993A

    专利类型

  • 公开/公告日2005-05-12

    原文格式PDF

  • 申请/专利权人 SANGAKU RENKEI KIKO KYUSHU:KK;

    申请/专利号JP20030358643

  • 发明设计人 YAMAMOTO KENJI;IWATA JUNICHI;

    申请日2003-10-20

  • 分类号C12Q1/37;C12N5/06;C12Q1/02;

  • 国家 JP

  • 入库时间 2022-08-21 22:37:32

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号